Table 1. Correlation between clinicopathological factors and survival of the 133 patients.

Characteristics		No. of patients	mOS (months)	aOS (months)	P value
Age	≤50 year	105	16	22.08	0.054
	>50 year	28	9	13.90
Ovarian metastases	Metachronous	64	17	22.90	0.087
	Synchronous	69	13	16.51
Gastrectomy	Yes	89	19	24.93	0.000
	No	44	9	11.56
Extra-ovarian metastasis	No	119	16	20.38	0.884
	Yes	14	16	17.07
Ascites	No	49	21	29.86	0.000
	Yes	84	13	13.94
Ovarian involvement	Unilateral	29	19	22.12	0.185
	Bilateral	104	15	18.65
Residual disease	No	50	20	28.75	0.000
	Yes	83	13	14.81

mOS: median overall survival.

aOS: average overall survival.